← Leaderboards
Cody S Nelson
Duke University
$124,844
Attributed
$124,844
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $45K · FY2017–19$50K$37.5K$25K$12.5K$0
'17
'18
'19
Funding mix
By agency
NIH$124,844 · 1
By mechanism
F30$124,844 · 1
Top collaborators
No co-investigators on record.
Most similar at Duke University
Same institution · by research overlap
- Herman F. Staats$31,192,841
- Carolyn B Coyne$16,278,724
- Barton F Haynes$531,570,874
- Cliburn C Chan$13,214,865
- Genevieve Giny Fouda Amou Ou$19,482,405
Others in their field
Other Emerging Leaders on “Adverse Outcome”
- Susan Abushakra · Alzheon, Inc.$47,265,244
- Kristin Aillon · Midwest Research Institute$25,857,783
- Abraham Aizer Brody · New York University School Of Medicine$21,887,280
- Ellen Gould Chadwick · Harvard University D/B/A Harvard School Of Public Health$21,828,548
- Barbara Halina Braffett · George Washington University$18,816,779
- Ionut Bebu · George Washington University$18,816,779
Research focus
Adverse OutcomeAmino AcidsAntibodiesAntibody RepertoireAntibody ResponseBaseBindingBrain InjuriesCenters For Disease Control And Prevention (U.S.)ChildChimeric ProteinsClinical TrialsCmv Glycoprotein BCognitive DeficitsCohortCollaborationsCongenital CytomegalovirusCongenital InfectionCrystallizationCytomegalovirusCytomegalovirus InfectionsCytomegalovirus VaccinesDeafnessAdjuvant
Grant awards (3)
Antibody and viral determinants of protection against CMV infection following gB/MF59 vaccination$45,016
F30 · FY2019 · HD · contact PI
Antibody and viral determinants of protection against CMV infection following gB/MF59 vaccination$35,784
F30 · FY2018 · HD · contact PI
Antibody and viral determinants of protection against CMV infection following gB/MF59 vaccination$44,044
F30 · FY2017 · HD · contact PI